This session will explore global trends in cancer care, focusing on advancements in prevention, diagnosis, and treatment, with a special emphasis on how these can be applied in India. Key topics include early detection, personalized treatments, digital health, innovative therapies like immunotherapy, palliative care, and public health initiatives. Experts will share insights on adapting cutting-edge global innovations to India’s unique healthcare challenges, such as access disparities and late-stage diagnoses. The session aims to provide actionable lessons for improving cancer care and strengthening the Indian healthcare system.

• Global cancer care trends and their relevance to India.
• Strategies for improving detection, treatment, and access in India.
• Opportunities for innovation in Indian oncology care.

This fireside chat will delve into the transformative potential of precision medicine and genomics in oncology. Experts will discuss how these innovations are changing the landscape of cancer treatment and what the future holds for personalized cancer care.

• Genomic Profiling and Personalized Treatment Plans
• Advancements in Gene Editing Technologies
• Integration of Genomic Data into Clinical Practice

Moderator:

Dr.Kumar Prabhash- Tata Memorial Hospital Mumbai –  Professor, Head of Department Medical Oncology

Panellists:

• Dr GVK Reddy, Hyderabad – Yashoda Hospital Malakpet, Hyderabad – Senior Consultant Medical & Hemato Oncologist
• Dr Prasad Narayanan, – Cytecare Hospitals, Bangalore – Senior Consultant & Director – Medical Oncology, Hemato Oncology & BMT
• Dr MVT Krishna Mohan, Hyderabad – Basavatarakam Indo American Cancer Hospital & Research Institute – Senior Medical Oncologist

Samir Desai – President & Head Business Unit – Biologics and Vaccines, Zydus

This panel discussion will explore how to balance cutting-edge technological advancements with the need for affordable and accessible cancer care. Experts from various sectors will discuss strategies to ensure that innovations in oncology benefit all segments of the population, particularly in resource-limited settings.

• Innovative Financing Models for Cancer Treatment
• Scaling Telemedicine and Remote Care
• Cost-Effective Diagnostic Tools
• Policy and Regulatory Frameworks
• Role of AI and Big data in oncology

Moderator:

Dr Niti Raizada – Fortis Hospital, Bannerghatta Road – Senior Director of Medical Oncology and Hemato Oncology, and Transplant Physician

Panellists:

• Dr Sandeep Goyle – Kokilaben Dhirubhai Ambani Hospital and research centre, Mumbai – Head of Department, Medical Oncology
• Dr Ajay Bapna – Bhagwan Mahaveer cancer hospital and research centre, Jaipur – Director & HOD Medical Oncology

• Dr Alok Gupta – Max Hospital Lucknow – Senior Director & Head of Medical Oncology.
• Adwaita Gore – Saifee Multispeciality Hospital & Nanavati Max Hospital – Senior medical oncologist and BMT Specialist

Dr. Ashish Joshi- MD, DM- Director & Co-founder- M|O|C Cancer Care & Research Centre

CAR-T cell therapy offers a revolutionary approach to treating blood cancers, but its adoption in India faces challenges such as high costs, complex manufacturing, and limited infrastructure. This fire side chat will explore:

• Mechanisms and its role in treating cancers like leukaemia and lymphoma
• Challenges in India’s healthcare system and potential solutions for wider access
• How local and global collaborations can drive adoption
• Examining regulatory pathways and the necessary policy changes for wider access
• Innovations that can reduce costs and improve outcomes

Moderator:

Rahul Purwar, Professor, IIT Bombay

Panellists:

Prof (Dr). Vijay Patil, Medical Oncologist, Tata Memorial Hospital

Dr. Puneet Jain, Consultant Hematologist, Hemato-Oncologist & Bone Marrow Transplant Physician

Dr. Sunil K Khetarpal – Director, AHPI

This panel discussion will focus on the importance of collaborative research in oncology. Participants will share insights on how breaking down silos between different research entities can lead to more effective treatments and better patient outcomes.

• Public-Private Partnerships
• Global Research Networks
• Overcoming Institutional Barriers
• Impact of Collaborative Research on Clinical Trials

Moderator:

Dr Shilpa Rao, Professor- Gen Surg ;Head Breast services;Admin incharge ESR, GSMC & KEM Hospital

Panellists:

• Dr. Amit Chakraborty, Surgical Oncologist, Breach Candy Hospital
• Dr. Sandeep De, Senior Consultant, Apollo Hospitals
• Dr. Preetam Jain, Medical Oncologist, Saifee Hospital
• Dr. Karishma Kirti – Consultant Breast Surgical Oncologist, Jaslok Hospital
• Dr Dipalee Borade, Radiation Oncologist, Apollo Hospitals
• Dr. Udip Maheshwari – MD DNB ECMO – Consultant Medical Oncologists – MOC India

Ramprasad Bhat, Vice President Strategy & Special Projects Head Oncology, Eris Lifescience

• Immunotherapy and Patient Quality of Life: Balancing Effectiveness and Side Effects
• Global Access to Immunotherapy: Equity, Affordability, and Challenges
• Immunotherapy and Cancer Survivorship: Long-Term Effects and Monitoring

Moderator:

Prof. (Dr.) Atul Sharma: Director Max Healthcare Saket , Medical Oncology ( He is Prof & Ex  HOD AIIMS

Panellists:

• Jyoti Bajpai, Founder General Secretary, Immuno-oncology Society of India
• Amit Awasthi, Senior Professor, Translational Health Science and Technology Institute
• Kshitij Joshi – MD DM DNB ECMO -C0-founder & Consultant Medical Oncologist – MOC India
• Chandrashekhar Pethe MD DM, Medical Oncologist , MOC India Nashik
• Dr. Pushpak Chirmade, Director and Founder, PCC Cancer Care and Research Centre

Explore the financial dynamics of cancer treatment, from funding innovative startups to how insurance policies affect the affordability and access to cutting-edge cancer therapies for patients.

• Venture Capital’s Impact on Cancer Innovation: Funding breakthrough treatments and biotech startups in oncology
• Insurance Models and Patient Access: Adapting coverage for high-cost, innovative cancer therapies
• Collaboration for Affordable Care: Partnering to create sustainable, cost-effective oncology treatment models

Moderator:

TBC

Panellists:

• Prem Pavoor, PhD, Managing Partner – Head of India Ventures, Eight Roads
• Mr. Vamesh Chovatia – Partner, Tata Capital

Dr. Sandeep Nayak, Director – Department of Surgical Oncology, Fortis Hospital